BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23919744)

  • 1. Anticancer agent ukrain and bortezomib combination is synergistic in 4T1 breast cancer cells.
    Savran B; Yerlikaya A; Erdoğan E; Genç O
    Anticancer Agents Med Chem; 2014 Mar; 14(3):466-72. PubMed ID: 23919744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bortezomib in combination with cisplatin and 5‑fluorouracil on 4T1 breast cancer cells.
    Yerlikaya A; Altıkat S; Irmak R; Cavga FZ; Kocacan SA; Boyaci I
    Mol Med Rep; 2013 Jul; 8(1):277-81. PubMed ID: 23660746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib.
    Yerlikaya A; Okur E; Ulukaya E
    Tumour Biol; 2012 Oct; 33(5):1385-92. PubMed ID: 22477712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ukrain, a plant derived semi-synthetic compound, exerts antitumor effects against murine and human breast cancer and induce protective antitumor immunity in mice.
    Bozeman EN; Srivatsan S; Mohammadi H; Daniels D; Shashidharamurthy R; Selvaraj P
    Exp Oncol; 2012 Dec; 34(4):340-7. PubMed ID: 23302993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of NSC-631570 (ukrain) alone and in combination with pathogen-associated molecules on cell cycle distribution and apoptosis induction of mouse melanoma cells with different biological properties.
    Skivka LM; Trompak OO; Kudryavets YI; Bezdenezhnykh NA; Susak YM
    Exp Oncol; 2010 Jul; 32(2):92-6. PubMed ID: 20693969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade.
    Yerlikaya A; Erin N
    Int J Mol Med; 2008 Dec; 22(6):817-23. PubMed ID: 19020781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB does not influence the induction of apoptosis by Ukrain.
    Mendoza J; Zamora R; Gallardo JC; Ceballos G; Aldana A; Espinosa M; Maldonado V; Melendez-Zajgla J
    Cancer Biol Ther; 2006 Jul; 5(7):788-93. PubMed ID: 16721042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
    Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
    BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ukrain on cell survival and apoptosis in the androgen-independent prostate cancer cell line PC-3.
    Venkatesh K; Govindaraj S; Ramachandran A; Kalimuthu S; Perumal E; Velayutham S; Jagadeesan A
    J Environ Pathol Toxicol Oncol; 2011; 30(1):11-9. PubMed ID: 21609312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells.
    Gagliano N; Moscheni C; Torri C; Donetti E; Magnani I; Costa F; Nowicky W; Gioia M
    Anticancer Drugs; 2007 Jul; 18(6):669-76. PubMed ID: 17762395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
    Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
    Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer cells retain the epithelial-related phenotype and modify mitotic spindle microtubules after the administration of ukrain in vitro.
    Gagliano N; Volpari T; Clerici M; Pettinari L; Barajon I; Portinaro N; Colombo G; Milzani A; Dalle-Donne I; Martinelli C
    Anticancer Drugs; 2012 Oct; 23(9):935-46. PubMed ID: 22700003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line.
    Yerlikaya A; Okur E; Baykal AT; Acılan C; Boyacı I; Ulukaya E
    J Proteomics; 2015 Jan; 113():315-25. PubMed ID: 25305590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reversal effect of LBH589 alone or in combination with bortezomib on drug-resistance in myeloid leukemia and its mechanism].
    Jiang XJ; Meng FY; Zhou HS; Wang Q; Wu FQ; Huang KK; Huang M; Wang ZX; Chen WW
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):537-42. PubMed ID: 22338177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosis.
    Lesinski GB; Raig ET; Guenterberg K; Brown L; Go MR; Shah NN; Lewis A; Quimper M; Hade E; Young G; Chaudhury AR; Ladner KJ; Guttridge DC; Bouchard P; Carson WE
    Cancer Res; 2008 Oct; 68(20):8351-60. PubMed ID: 18922907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in cultured Chinese hamster ovary cells by Ukrain and its synergistic action with etoposide.
    Kurochkin SN; Kolobkov SL; Votrin II; Voltchek IV
    Drugs Exp Clin Res; 2000; 26(5-6):275-8. PubMed ID: 11345038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells.
    Gatti L; Benedetti V; De Cesare M; Corna E; Cincinelli R; Zaffaroni N; Zunino F; Perego P
    J Inorg Biochem; 2012 Aug; 113():94-101. PubMed ID: 22717676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic and apoptotic effects of bortezomib and gefitinib compared to alkylating agents on human glioblastoma cells.
    Pédeboscq S; L'Azou B; Passagne I; De Giorgi F; Ichas F; Pometan JP; Cambar J
    J Exp Ther Oncol; 2008; 7(2):99-111. PubMed ID: 18771084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant phenotype of renal cell carcinoma cells is switched by ukrain administration in vitro.
    Gagliano N; Pettinari L; Aureli M; Martinelli C; Colombo E; Costa F; Carminati R; Volpari T; Colombo G; Milzani A; Dalle-Donne I; Gioia M
    Anticancer Drugs; 2011 Sep; 22(8):749-62. PubMed ID: 21799470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
    Cordes N; Plasswilm L; Bamberg M; Rodemann HP
    Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.